|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Lung Diseases, National Heart, Lung and Blood Institute, Bethesda, MD.
Correspondence to: Suzanne S. Hurd, PhD, PO Box 34262, Bethesda, MD 20827; e-mail: shurd{at}prodigy.net
COPD is the only leading cause of death that is increasing in prevalence worldwide. The lack of international standardization in the diagnosis of COPD means that intercountry comparisons are difficult. This review highlights the Global Initiative for Obstructive Lung Disease, a program aimed at focusing attention on the importance of COPD as a global health problem, and designing and implementing consistent international strategies for effective prevention, diagnosis, and treatment.
Key Words: COPD diagnosis Global Initiative for Obstructive Lung Disease worldwide prevalence
This article has been cited by other articles:
![]() |
S. Inoue, H. Nakamura, K. Otake, H. Saito, K. Terashita, J. Sato, H. Takeda, and H. Tomoike Impaired Pulmonary Inflammatory Responses Are a Prominent Feature of Streptococcal Pneumonia in Mice with Experimental Emphysema Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 764 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Mannino COPD* : Epidemiology, Prevalence, Morbidity and Mortality, and Disease Heterogeneity Chest, May 1, 2002; 121(5_suppl): 121S - 126S. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |